These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18714175)

  • 1. Primers on molecular pathways: nuclear receptors in pancreatic cancer. The ligand-independent way.
    Nacusi LP; Debes JD
    Pancreatology; 2008; 8(4-5):422-4. PubMed ID: 18714175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the repertoire of nuclear receptor binding sites in genomes.
    Cotnoir-White D; Laperrière D; Mader S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cephalochordate amphioxus: a key to reveal the secrets of nuclear receptor evolution.
    Lecroisey C; Laudet V; Schubert M
    Brief Funct Genomics; 2012 Mar; 11(2):156-66. PubMed ID: 22441553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha.
    Barry JB; Giguère V
    Cancer Res; 2005 Jul; 65(14):6120-9. PubMed ID: 16024613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corepressor recruitment by agonist-bound nuclear receptors.
    White JH; Fernandes I; Mader S; Yang XJ
    Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear xenobiotic receptors: integrating gene regulation to physiological functions.
    He J; Xie W
    Prog Mol Biol Transl Sci; 2009; 87():87-116. PubMed ID: 20374702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin remodeling and nuclear receptor signaling.
    Buranapramest M; Chakravarti D
    Prog Mol Biol Transl Sci; 2009; 87():193-234. PubMed ID: 20374705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
    Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
    Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endocrine signaling system mediated by nuclear receptors].
    Umesono K
    Nihon Rinsho; 1998 Jul; 56(7):1693-8. PubMed ID: 9702039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS; Coon CI; Rosen ED; Suh N; Sporn MB; Brinckerhoff CE
    Mol Pharmacol; 2004 Feb; 65(2):309-18. PubMed ID: 14742672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flip side: Identifying small molecule regulators of nuclear receptors.
    Schulman IG; Heyman RA
    Chem Biol; 2004 May; 11(5):639-46. PubMed ID: 15157874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuclear receptor-mediated signaling pathway].
    Kato S
    Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):133-40. PubMed ID: 11031742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.